QA: Mirati Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2018_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 155,759,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 525,000
3 remainder_Assets 962,000
4 LiabilitiesCurrent 13,644,000
5 LiabilitiesNoncurrent 314,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,104,266
9 ResearchAndDevelopmentExpense 51,685,902
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,026,424
13 remainder_ComprehensiveNetIncome -58,023
  yvar yval
0 Assets 157,246,000
1 Liabilities 13,958,000
2 Expenses 64,790,168
3 Revenues 0
4 StockholdersEquity 143,288,000
5 NetIncome -63,763,744
6 ComprehensiveNetIncome -63,792,756
7 BaseVar 118,539,308
8 EconomicCapitalRatiobeforeLimitedLiability 2.90
9 EconomicCapitalRatio 3.62

Edgar->Model Mapping

Feature Distribution

Change over Time